| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 6.0 | $0-$5k | 0.00 |
Summary
A vulnerability marked as critical has been reported in Apple macOS up to 11.1. This vulnerability affects unknown code of the component WebKit. This manipulation causes access control. This vulnerability is tracked as CVE-2021-1801. The attack is possible to be carried out remotely. No exploit exists. It is suggested to upgrade the affected component.
Details
A vulnerability was found in Apple macOS up to 11.1 (Operating System). It has been declared as critical. Affected by this vulnerability is an unknown code of the component WebKit. The manipulation with an unknown input leads to a access control vulnerability. The CWE definition for the vulnerability is CWE-284. The product does not restrict or incorrectly restricts access to a resource from an unauthorized actor. As an impact it is known to affect confidentiality, integrity, and availability.
The weakness was disclosed 02/01/2021 by Eliya Stein as HT212147 as confirmed advisory (Website). The advisory is shared at support.apple.com. This vulnerability is known as CVE-2021-1801. It demands that the victim is doing some kind of user interaction. Neither technical details nor an exploit are publicly available. MITRE ATT&CK project uses the attack technique T1068 for this issue. The advisory points out:
Maliciously crafted web content may violate iframe sandboxing policy
The vulnerability scanner Nessus provides a plugin with the ID 241427 (RHEL 7 : webkitgtk4 (RHSA-2025:10364)), which helps to determine the existence of the flaw in a target environment.
Upgrading to version 11.2 eliminates this vulnerability. A possible mitigation has been published immediately after the disclosure of the vulnerability. The advisory contains the following remark:
This issue was addressed with improved iframe sandbox enforcement.
The vulnerability is also documented in the vulnerability database at Tenable (241427). If you want to get the best quality for vulnerability data then you always have to consider VulDB.
Product
Type
Vendor
Name
Version
License
Website
- Vendor: https://www.apple.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 6.3VulDB Meta Temp Score: 6.0
VulDB Base Score: 6.3
VulDB Temp Score: 6.0
VulDB Vector: 🔍
VulDB Reliability: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
Exploiting
Class: Access controlCWE: CWE-284 / CWE-266
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Nessus ID: 241427
Nessus Name: RHEL 7 : webkitgtk4 (RHSA-2025:10364)
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
Reaction Time: 🔍
0-Day Time: 🔍
Exposure Time: 🔍
Upgrade: macOS 11.2
Timeline
12/08/2020 🔍02/01/2021 🔍
02/01/2021 🔍
02/03/2021 🔍
07/09/2025 🔍
Sources
Vendor: apple.comAdvisory: HT212147
Researcher: Eliya Stein
Status: Confirmed
CVE: CVE-2021-1801 (🔍)
GCVE (CVE): GCVE-0-2021-1801
GCVE (VulDB): GCVE-100-169117
scip Labs: https://www.scip.ch/en/?labs.20180712
Entry
Created: 02/03/2021 14:13Updated: 07/09/2025 11:53
Changes: 02/03/2021 14:13 (8), 02/03/2021 14:14 (11), 02/03/2021 14:17 (28), 02/23/2021 08:41 (4), 07/09/2025 11:53 (16)
Complete: 🔍
Cache ID: 216::103
If you want to get the best quality for vulnerability data then you always have to consider VulDB.

No comments yet. Languages: en.
Please log in to comment.